Operating Lease, Right-of-Use Asset in USD of Janux Therapeutics, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Janux Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2025.
  • Janux Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2025 was $18.9M, a 3.88% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)

Janux Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $18.9M -$763K -3.88% Sep 30, 2025 10-Q 2025-11-06
Q2 2025 $18.5M -$1.62M -8.04% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $18.9M -$1.58M -7.74% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $19.3M -$1.55M -7.45% Dec 31, 2024 10-Q 2025-11-06
Q3 2024 $19.7M -$1.52M -7.18% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $20.1M -$1.49M -6.93% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $20.5M -$1.47M -6.69% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $20.8M -$1.44M -6.47% Dec 31, 2023 10-K 2025-02-27
Q3 2023 $21.2M -$1.46M -6.42% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $21.6M -$1.19M -5.22% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $21.9M +$21.8M +16767% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $22.3M +$22.1M +11943% Dec 31, 2022 10-K 2024-03-08
Q3 2022 $22.7M +$22.4M +9422% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $22.8M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $130K Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $185K +$185K Dec 31, 2021 10-K 2023-03-10
Q3 2021 $238K Sep 30, 2021 10-Q 2021-11-09
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.